Susu Zhang
Contributed to a study showing that salvianolic acid B improves motor recovery after spinal cord injury in association with AKT/mTOR/HIF-1α activation and blood-vessel growth
Clinical researcher · Lishui Central Hospital / Wenzhou Medical University, China
Susu Zhang is affiliated with Lishui Central Hospital (Fifth Affiliated Hospital of Wenzhou Medical University). The 2026 study co-authored by Susu Zhang combined network pharmacology with a rat spinal-cord-injury model to show that Salvianolic Acid B (predicted by molecular docking to bind AKT1) improves motor recovery in association with activation of the AKT/mTOR/HIF-1α axis and new blood vessel growth at the injury site.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | A | Salvianolic Acid B Enhances Motor Function Recovery after Spinal Cord Injury in Association with AKT/mTOR/HIF-1α Pathway Activation and Angiogenesis. YAO2026 Co-author on the spinal-cord-injury study linking Salvianolic Acid B's pro-angiogenic, motor-recovery benefit to AKT/mTOR/HIF-1α activation. |
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.